Feng Huang

Zhenjiang, 212013, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Targeting the syncytiotrophoblast: A central player in the pathogenesis and therapy of preeclampsia.

Targeting the syncytiotrophoblast: A central player in the pathogenesis and therapy of preeclampsia.

Journal: Pathology, research and practice
Published: January 16, 2026

Exploring the anti-aging potential of phytoestrogens: focus on molecular mechanisms and menopausal symptom modulation.

Exploring the anti-aging potential of phytoestrogens: focus on molecular mechanisms and menopausal symptom modulation.

Journal: Frontiers in nutrition
Published: June 23, 2025

KHDRBS3-mediated upregulation of circ_0024107 in gastric cancer cells and GC-MSCs synergistically drives gastric cancer cell migration and invasion.

KHDRBS3-mediated upregulation of circ_0024107 in gastric cancer cells and GC-MSCs synergistically drives gastric cancer cell migration and invasion.

Journal: In vitro cellular & developmental biology. Animal
Published: February 18, 2025

Gastric cancer cells shuttle lactate to induce inflammatory CAF-like phenotype and function in bone marrow-derived mesenchymal stem cells.

Gastric cancer cells shuttle lactate to induce inflammatory CAF-like phenotype and function in bone marrow-derived mesenchymal stem cells.

Journal: Molecular immunology
Published: December 20, 2024

FGFR3 signaling is essential for gastric cancer cell triggering the transition of BM-MSCs into tumor-associated MSCs.

FGFR3 signaling is essential for gastric cancer cell triggering the transition of BM-MSCs into tumor-associated MSCs.

Journal: Differentiation; research in biological diversity
Published: October 15, 2024

Corrigendum: Exosomal CD44 transmits lymph node metastatic capacity between gastric cancer cells via YAP-CPT1A-mediated FAO reprogramming.

Corrigendum: Exosomal CD44 transmits lymph node metastatic capacity between gastric cancer cells via YAP-CPT1A-mediated FAO reprogramming.

Journal: Frontiers in oncology
Published: September 12, 2024

GC-MSCs transcriptionally upregulate SALL4 in gastric cancer through miR-4669/TIMP3/β-catenin signaling.

GC-MSCs transcriptionally upregulate SALL4 in gastric cancer through miR-4669/TIMP3/β-catenin signaling.

Journal: Cellular signalling
Published: August 16, 2024

Erratum: Circular RNA Hsa_circRNA_101996 promotes the development of Gastric Cancer via Upregulating Matrix Metalloproteinases-2/Matrix Metalloproteinases-9 through MicroRNA-143/Ten-eleven translocation-2 Pathway: Erratum.

Erratum: Circular RNA Hsa_circRNA_101996 promotes the development of Gastric Cancer via Upregulating Matrix Metalloproteinases-2/Matrix Metalloproteinases-9 through MicroRNA-143/Ten-eleven translocation-2 Pathway: Erratum.

Journal: Journal of Cancer
Published: April 05, 2024

Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database.

Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database.

Journal: Scientific reports
Published: November 22, 2023

Gastric cancer cell-originated small extracellular vesicle induces metabolic reprogramming of BM-MSCs through ERK-PPARγ-CPT1A signaling to potentiate lymphatic metastasis.

Gastric cancer cell-originated small extracellular vesicle induces metabolic reprogramming of BM-MSCs through ERK-PPARγ-CPT1A signaling to potentiate lymphatic metastasis.

Journal: Cancer cell international
Published: February 09, 2023

GC‑MSC‑derived circ_0024107 promotes gastric cancer cell lymphatic metastasis via fatty acid oxidation metabolic reprogramming mediated by the miR‑5572/6855‑5p/CPT1A axis.

GC‑MSC‑derived circ_0024107 promotes gastric cancer cell lymphatic metastasis via fatty acid oxidation metabolic reprogramming mediated by the miR‑5572/6855‑5p/CPT1A axis.

Journal: Oncology reports
Published: January 11, 2023

Antagonizing EZH2 combined with vitamin D3 exerts a synergistic role in anti-fibrosis through bidirectional effects on hepatocytes and hepatic stellate cells.

Antagonizing EZH2 combined with vitamin D3 exerts a synergistic role in anti-fibrosis through bidirectional effects on hepatocytes and hepatic stellate cells.

Journal: Journal of gastroenterology and hepatology
Published: December 14, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026